Bank of America Securities Raises HENGAN INT'L Target Price to HK$30, Forecasts 8% Core Net Profit Growth for Second Half

Stock News02-11 15:17

Bank of America Securities has released a research report adjusting its forecast for HENGAN INT'L (01044). The report indicates a reduction in the core net profit forecasts for 2025 and 2026 by 3% and 1%, respectively. However, citing an improved competitive landscape within the industry, the target price-to-earnings ratio has been increased to 13 times, leading to an 18% rise in the target price to HK$30. While the company lacks strong long-term growth drivers, it offers an attractive dividend yield. The "Neutral" rating was reaffirmed.

The bank anticipates that HENGAN INT'L's revenue for the second half of 2025 will increase by 1% year-on-year to RMB 10.9 billion, attributed to sustained improvement across its three main business segments. Tissue product sales are expected to grow by 5% year-on-year, accelerating from the 3% growth seen in the first half.

Furthermore, the gross profit margin for the second half is projected to improve compared to the first half, reaching 33.1%. This enhancement is primarily driven by an improved product mix and normalized raw material costs in the tissue business. The core net profit for the second half of 2025 is forecast to grow by 8% year-on-year to RMB 1 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158815430?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-11 15:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158815430","market":"sg","top_or_hot":-1,"title":"Bank of America Securities Raises HENGAN INT'L Target Price to HK$30, Forecasts 8% Core Net Profit Growth for Second Half","media":"Stock News","content":"<p>Bank of America Securities has released a research report adjusting its forecast for HENGAN INT'L (01044). The report indicates a reduction in the core net profit forecasts for 2025 and 2026 by 3% and 1%, respectively. However, citing an improved competitive landscape within the industry, the target price-to-earnings ratio has been increased to 13 times, leading to an 18% rise in the target price to HK$30. While the company lacks strong long-term growth drivers, it offers an attractive dividend yield. The \"Neutral\" rating was reaffirmed.</p>\n<p>The bank anticipates that HENGAN INT'L's revenue for the second half of 2025 will increase by 1% year-on-year to RMB 10.9 billion, attributed to sustained improvement across its three main business segments. Tissue product sales are expected to grow by 5% year-on-year, accelerating from the 3% growth seen in the first half.</p>\n<p>Furthermore, the gross profit margin for the second half is projected to improve compared to the first half, reaching 33.1%. This enhancement is primarily driven by an improved product mix and normalized raw material costs in the tissue business. The core net profit for the second half of 2025 is forecast to grow by 8% year-on-year to RMB 1 billion.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bank of America Securities Raises HENGAN INT'L Target Price to HK$30, Forecasts 8% Core Net Profit Growth for Second Half</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBank of America Securities Raises HENGAN INT'L Target Price to HK$30, Forecasts 8% Core Net Profit Growth for Second Half\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-11 15:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bank of America Securities has released a research report adjusting its forecast for HENGAN INT'L (01044). The report indicates a reduction in the core net profit forecasts for 2025 and 2026 by 3% and 1%, respectively. However, citing an improved competitive landscape within the industry, the target price-to-earnings ratio has been increased to 13 times, leading to an 18% rise in the target price to HK$30. While the company lacks strong long-term growth drivers, it offers an attractive dividend yield. The \"Neutral\" rating was reaffirmed.</p>\n<p>The bank anticipates that HENGAN INT'L's revenue for the second half of 2025 will increase by 1% year-on-year to RMB 10.9 billion, attributed to sustained improvement across its three main business segments. Tissue product sales are expected to grow by 5% year-on-year, accelerating from the 3% growth seen in the first half.</p>\n<p>Furthermore, the gross profit margin for the second half is projected to improve compared to the first half, reaching 33.1%. This enhancement is primarily driven by an improved product mix and normalized raw material costs in the tissue business. The core net profit for the second half of 2025 is forecast to grow by 8% year-on-year to RMB 1 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999014674.SGD","symbol_name":"Nikko AM All China Equity A SGD","start_time":0,"source_url":"","article_id":"1158815430","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158815430","pubTimestamp":1770794226,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Bank of America Securities has released a research report adjusting its forecast for HENGAN INT'L (01044). The report indicates a reduction in the core net profit forecasts for 2025 and 2026 by 3%...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161027":"证券","SG9999014674.SGD":"Nikko AM All China Equity A SGD","BK1500":"做空集合股","01044":"恒安国际","BK1207":"个人用品"},"translate_title":"美银证券上调恒安国际目标价至30港元预测下半年核心纯利增长8%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"01044":1},"content_text":"Bank of America Securities has released a research report adjusting its forecast for HENGAN INT'L (01044). The report indicates a reduction in the core net profit forecasts for 2025 and 2026 by 3% and 1%, respectively. However, citing an improved competitive landscape within the industry, the target price-to-earnings ratio has been increased to 13 times, leading to an 18% rise in the target price to HK$30. While the company lacks strong long-term growth drivers, it offers an attractive dividend yield. The \"Neutral\" rating was reaffirmed.\nThe bank anticipates that HENGAN INT'L's revenue for the second half of 2025 will increase by 1% year-on-year to RMB 10.9 billion, attributed to sustained improvement across its three main business segments. Tissue product sales are expected to grow by 5% year-on-year, accelerating from the 3% growth seen in the first half.\nFurthermore, the gross profit margin for the second half is projected to improve compared to the first half, reaching 33.1%. This enhancement is primarily driven by an improved product mix and normalized raw material costs in the tissue business. The core net profit for the second half of 2025 is forecast to grow by 8% year-on-year to RMB 1 billion.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158815430","isCrawlerRequest":true}